XNAS
ALP
Market cap1mUSD
Nov 12, Last price
3.10USD
1D
-4.32%
1Q
-64.24%
IPO
-99.97%
Name
Portage Biotech Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Alpha Compute Corp. (Nasdaq: ALP) is a high-performance GPU infrastructure and confidential-compute technology company built for the artificial intelligence economy. Structured as a holding company focused on sovereign AI compute, Alpha Compute owns the infrastructure that powers modern intelligence and enforces privacy directly at the hardware level. That foundation positions the company to build and acquire businesses that depend on confidential compute and artificial intelligence. Alpha Compute's mission is to support clients, subsidiaries, and partners across critical sectors such as finance, defense, intelligence, and media as they adapt to a rapidly changing AI landscape. The company provides the core framework any organization needs to run secure, confidential computing environments. Alpha Compute is domiciled in the British Virgin Islands, with offices in New York, Los Angeles, Miami, Amsterdam, and Toronto.
Key people
Andrea Park
Chief Financial Officer · since 2024
Chief Financial Officer, Secretary · since 2023
Robert Kramer
Chief Scientific Officer · since 2019
Justin Fairchild
Vice President - Development · since 2022
Brian Wiley
Chief Business Officer · since 2022
Alexander Pickett
Chief Executive Officer, Director · since 2024
Ian Walters
Chairman of the Board · since 2024
Independent Director · since 2022
Jean-Christophe Renondin
Independent Director · since 2024
Independent Director · since 2022
Justin Stebbing
Independent Director · since 2024
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||